More From BioPortfolio on "Sanofi Expands MS Portfolio With BTK Inhibitor From Principia"

Relevant Topics

Clincial TrialsIn a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Multiple Sclerosis MSMultiple sclerosis (MS) is the most common disabling neurological condition affecting 100,000 young adults in the UK.
The condition results from autoimmune damage to myelin, causing interference in nerve signaling. Symptoms experienced depend on the pa...